维普中文期刊产品整合服务
184篇 您的检索式:作者名="Oh DY"
    题名 作者 年代 出处 被引量
1The clinicopathologic characteris-tics and prognostic significance of triple-negativity in node-negativebreast cancer显示文摘Rhee J Han SW Oh DY 2008BMC Cancer2008,8,3:1
2Increased macrophage migration into adipose tissues in obese mice显示文摘Oh DY Morinaga H Talukdar S 2012Diabetes2012,61,2:1
3Combination chemotherapy with capecitabine and cisplatin for patients with metastatic hepatocellu-lar carcinoma显示文摘Lee JO Lee KW Oh DY 0,,8:1
4Omega 3 fatty acids and GPR120显示文摘Oh DY Olefsky JM 2012Cell Metab2012,15,5:1
5A muhicenter phase II study of gemcitabine and S-1 combination chemotherapy in patients with unresectable pancreatic cancer 显示文摘OH DY CHA Y CHOI IS 2010Cancer Chemother Pharmacol2010,65,3:1
6Correction of earlobe cleft with tongue-in-groove technique 显示文摘Oh DY Kim SW Ahn ST 2011J Craniofac Surg2011,22,5:1
7Molecular characterization of the first Aichi viruses isolated in Europe and in South America显示文摘Oh DY Silva PA Haurader B 2006Arch Virol2006,151,6:1
8Viral agents of acute gas-troenteritis in German children : prevalence and molecular diversity 显示文摘OH DY GAEDICKE G SCHREIER E 2003JMed Virol2003,71,1:1
9Thymidylate synthase polymorphisms and mBNA expression are independent chemotherapy predictive markers in csophageal adenoearcinoma patients显示文摘Kuramochi H Tanaka K Oh D Lehman BJ l)unst CM Yang DY 2008lnt J Oneol2008,32,1:1
10The clinicopathologic characteris- tics and prognostic significance of triple - negativity in node - negative breast cancer 显示文摘Rhee J Han SW Oh DY 2008BMC Cancer2008,23,8:1
11Phase 2 study of everolim- usmonotherapy in patients with nonfunctioning neuroendoerine tumors or pheochromoeytomas/paragangliomas 显示文摘Oh DY Kim TW Park YS 2012Cancer2012,118,24:1
12Metaplastic breast carcinoma: clinicopathologic features and prognostic value of triple negativity 显示文摘Lim KH Oh DY Chie EK 2010Jan J Clin Oncol2010,40,2:1
13The clinicopathologic characteristics and prognostic significance of triple-negativity in node-negative breast cancer 显示文摘Rhee J Han SW Oh DY 2008BMC Cancer2008,8,:1
14Phase I study of sunitinib plus capecitabine/cisplatin or capecitabine/oxaliplatin in advanced gastric cancer显示文摘LEE KW PARK SR OH DY 2013Invest New Drugs2013,31,6:1
15Expression of the promoter for the maltogenic amylase gene in Bacillus subtilis 168显示文摘KIM DY CHA CH OH WS 2004J Mierobiol2004,42,4:1
16Phase Ⅱ study and biomarker analysis of cetuximab combined with modified FOLFOX6 in advanced gastric cancer显示文摘Han SW Oh DY Im SA 0,,02:1
17Increased macrophage migration into adipose tissue in obese mice显示文摘Oh DY Morinaga H Talukdar S 0,,02:1
18Transformation of mouse liver cells by methylcholanthrene leads to phenotypic changes associated with epithelial-mesenchymal transition 显示文摘Oh J Kwak JH Kwon DY 2014Toxicol Res2014,30,4:1
19Phase II study and biomarker analysis of cetuximab combined with modified FOLFOX6 in advanced gastric cancer显示文摘Han SW Oh DY Im SA 2009Br J Cancer2009,100,2:1
20Combination chemotherapy with eapeeitabine and cisplatin for patients with metastatic hepatoeellular carcinoma显示文摘Lee JO Lee KW Oh DY 2009Ann Oneol2009,20,8:1
返回顶部 每页显示:
共10页 首页 上一页 第1页 下一页 末页 /10 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费